NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. - Wikidata - wikimedia - TriplyDB

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.

http://www.wikidata.org/entity/Q46863661

about

Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia Neurotransmitter receptors in the life and death of oligodendrocytes The role of neuronal complexes in human X-linked brain diseases Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis Rodent Hypoxia-Ischemia Models for Cerebral Palsy Research: A Systematic Review Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage Adaptive myelination from fish to man.The Role of Astrocytes in Multiple Sclerosis Progression Glutamatergic Transmission: A Matter of Three Lactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interaction Neuropathogenesis of HIV-1-associated neurocognitive disorders: a possible involvement of D-serine Ionic regulation of cell volume changes and cell death after ischemic stroke.Role of NG2 expressing cells in addiction: a new approach for an old problem Glutamate receptor ion channels: structure, regulation, and function Glutamate excitotoxicity inflicts paranodal myelin splitting and retraction Dual-specific phosphatase-6 (Dusp6) and ERK mediate AMPA receptor-induced oligodendrocyte death NMDA receptor couples Rac1-GEF Tiam1 to direct oligodendrocyte precursor cell migration Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4 Identification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia-ischemia Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis Genome-wide association study of severity in multiple sclerosis.Oligodendrocytes: biology and pathology Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes.Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus.Alteration of synaptic connectivity of oligodendrocyte precursor cells following demyelination.Pathophysiology of glia in perinatal white matter injury.Comparative analysis of putative pathogenesis-related gene expression in two Rhizoctonia solani pathosystems.White matter injury in ischemic stroke.Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined.NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study.Excitability and synaptic communication within the oligodendrocyte lineage HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation White matter loss in a mouse model of periventricular leukomalacia is rescued by trophic factors MK801 attenuates secondary injury in a mouse experimental compression model of spinal cord trauma.Influence of the NR3A subunit on NMDA receptor functions.

P2860

Q21145719-33CB4F3C-1575-42F1-A97D-53CD083AC1F2 Q24289198-896568A0-314F-4428-991E-04C4C07ED376 Q24671657-45B1F03C-F3FA-42E6-B639-9B4026F7D268 Q24680472-F4BCDC24-676B-49D1-87C4-3C3473631FFA Q26740330-9015061A-B39A-4B60-BDC5-C956A2ECD0D0 Q26747485-DF13D87D-3E00-4777-AA8C-F5B9AD2E0121 Q26768210-AAFEE860-9A3C-4902-A8C3-B63DAE30B976 Q26779643-3B2010C0-FC99-4A8C-8788-BF0C59EAD1AD Q26782843-8BFCEA31-B01B-462B-BF2F-7DF87E5A4AE4 Q26783363-7413BD9A-02E1-4F6A-AB7B-8C076946F11F Q26851808-C7361164-559D-42EC-A24C-83FE1767B6E0 Q27024914-EE792F16-08AB-422A-932A-3078EDC655C3 Q27691821-EB85D774-2497-442B-87C2-F41480BDFC68 Q28082885-263B5DB8-28EC-419D-9FA8-FAADA47C90DB Q28290774-30388CCF-B33C-459B-82E2-68D3D354FF15 Q28475977-6AC8FF1A-4425-4AAD-BEE7-3EB47C98EAC8 Q28566860-2A633643-278D-4C07-97AC-DF5BCB0BD889 Q28580426-AD846165-0FE3-48E7-917C-649FB7E7BEB4 Q28582010-37EAC5EF-2E2A-4B94-B082-D82043D9BCD5 Q28771339-BF9A9961-9EFB-4B80-93E2-0B344E1E6035 Q28943414-A4CA7A84-8978-4950-9FEB-2082CD73EF4A Q29417054-0A5E6D22-FBAF-4D45-81C1-CFCBD7D95060 Q30051584-14B13E7E-FC50-4CCA-AF84-44FF0B8FC891 Q30387014-468EAF23-A485-4F98-BE2C-4EC5378307D4 Q30388470-DD9C11A0-8916-4251-BE3A-FF83CCB04A52 Q30485404-50455B96-3BB4-4475-8584-F2EB885C8250 Q30628440-9527108D-8D71-49F8-8FB3-8938F3DB5675 Q30790294-376A7EA3-03F0-4EF4-BC55-04FFEE0C13DA Q31030811-0DA1F99C-A2A0-4FC5-BB3B-80624399F8DE Q31080285-BD02C993-2108-4E32-8DBF-6081D829A3C8 Q33410173-75FD9603-14A9-49E3-A36B-5AF862B62030 Q33516828-859130D2-B248-416D-8D73-A204D205F5A8 Q33565598-1DD2AFD2-6728-4C76-B53B-280BF53D7184 Q33626978-F6F5DD95-C45E-4489-8B8D-44B2494CBA52 Q33657315-ADBB8DE1-4170-47ED-9187-4BF3C8386E42 Q33725968-073C0868-A8CD-43C0-AB68-8C93E2EEDBD7 Q33757971-C23A8B10-79FB-4E11-82DB-98C3FF3D2D58 Q33772241-426796DB-1566-4318-935B-705E091026A2 Q33872820-C8ED7C64-7806-442F-9F31-1EF88DD86A8B Q33906149-7999CF51-0467-4BB4-8247-88A8247C7A69

P2860

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.

http://www.wikidata.org/entity/Q46863661

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.

@en

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.

@nl

type

label

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.

@en

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.

@nl

prefLabel

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.

@en

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.

@nl

P1433

Q46863661-7C5FC91C-17E5-445D-BE40-2EB3E6CDAC9E

P1476

Q46863661-460EAB55-A54C-4C58-BBC7-2F50ED8201A9

P2093

Q46863661-4C0EE2AE-49A1-4F05-9D2F-187C18B36E81

Q46863661-690381A3-3099-4F41-952A-A123E9ABCCB2

P2860

Q46863661-20371199-4C96-40B7-AE50-CAE80A8644AA

Q46863661-25DA76C3-E4A6-4CE6-B778-47D933288617

Q46863661-2A6D62DC-8E5A-437C-916F-E7C75CB45015

Q46863661-2CD05BD0-1E4D-4072-86A0-46898F4960D8

Q46863661-2EBA6B28-E74A-448C-A03E-CE0845C8D825

Q46863661-41991981-8B30-4F24-9FBE-A1A60867798F

Q46863661-4534FB09-D6CB-49EB-8AA7-6F79B0716611

Q46863661-45632A16-D7F8-4052-B799-0B1FAA494934

Q46863661-5EE5AC76-A185-467A-BCEE-C4FF1D9E9156

Q46863661-86F7A517-6FE1-4472-86EE-4B4F4524A429

P2888

Q46863661-2C1E99C6-12B5-4CB2-BD68-C7F798B09815

P304

Q46863661-CE8FC347-A28A-4942-AE3C-04A1D11F8342

P31

Q46863661-F9AE2EE3-F31F-49EF-9099-279126833EFD

P356

Q46863661-ACFE482B-5CA8-4A23-97BC-71DFA2C95CAB

P407

Q46863661-5BA696AE-4264-4A63-A71B-C40A70D2CB58

P433

Q46863661-73EF60BF-6EB1-4552-8F18-E2E2BD849FFA

P478

Q46863661-CEFA2117-42AE-4169-8CAF-FC3A0682263A

P577

Q46863661-48F281F8-96FE-49A8-A071-A399FA1FF8AA

P5875

Q46863661-3CE5529A-2DC8-49AA-BE0A-8412FB538554

P6179

Q46863661-C161821C-BF7B-4531-B033-BCDA1861FB66

P698

Q46863661-F9DFE1A4-7C35-43BC-A9DA-777443B1230D

P921

Q46863661-CC17021A-2BE6-4A7A-B488-0ED5AC19D67D

P356

P1433

P1476

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.

@en

P2093

Michael G Salter

http://www.w3.org/2001/XMLSchema#string

Robert Fern

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability.

Protein synthesis in axons and terminals: significance for maintenance, plasticity and regulation of phenotype. With a critique of slow transport theory.

Glutamate receptors in glia: new cells, new inputs and new functions.

Cell death and control of cell survival in the oligodendrocyte lineage.

Functional N-methyl-D-aspartate receptors in O-2A glial precursor cells: a critical role in regulating polysialic acid-neural cell adhesion molecule expression and cell migration

Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes.

NMDA receptors are expressed in oligodendrocytes and activated in ischaemia.

Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons.

AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes.

Mechanism of acute ischemic injury of oligodendroglia in early myelinating white matter: the importance of astrocyte injury and glutamate release.

P2888

P304

1167-1171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE04301

http://www.w3.org/2001/XMLSchema#string

P407

P433

7071

http://www.w3.org/2001/XMLSchema#string

P478

438

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7399146

http://www.w3.org/2001/XMLSchema#string

P6179

1009535361

http://www.w3.org/2001/XMLSchema#string

P698

16372012

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte